RPL17 and neoplasm: For example, increased chromatin availability at the CD56 genomic region, together with chemokine upregulation including CXCL9, CXCL10, and CXCL12, enhances tumor infiltration by PD-1/TIM3/LAG3-modified CAR-T cells.